首页> 外文会议>World biomaterials congress >PEG-PLGA nanoparticles: investigation of BBB translocation according to PEG chain length using a primary endothelial cell permeability model
【24h】

PEG-PLGA nanoparticles: investigation of BBB translocation according to PEG chain length using a primary endothelial cell permeability model

机译:PEG-PLGA纳米颗粒:使用一级内皮细胞通透性模型根据PEG链长研究BBB易位

获取原文
获取外文期刊封面目录资料

摘要

The Blood-Brain Barrier (BBB) acts as a physical and metabolic barrier between the Central Nervous System (CNS) and the systemic circulation. This complex cell assembly results in a protective, quasi-impermeable barrier for most therapeutic molecules. Nanotechnologies have been used with various success rates to overcome this problem. In particular, nanoparticles (NP) from the FDA-approved poly(0, L-lactide-co-glycolide) (PLGA), grafted with poly(ethylene glycol) (PEG), have been widely investigated. This alternative confers them reduced loxicity, increased circulation time and BBB penetration. However, no systematic studies have been initiated so far to explore the role of PEG chain length on endocytosls and transcytosis of NP across the BBB. This study aimed therefore to compare the translocation rate of PEG-PLGA nanoparticles across a primary endothelial cell model, according to PEG chain length. PEGylated diblock polymers were synthesized as previously reported by DCC coupling reaction between PLGA chains (24 kDa) and mPEG chains of different lengths (1,2,5 and 10 kDa). Polymers were characterized by GPC, ~1H-NMR and FTIR. In parallel, PLGA chains were covalently labelled with the flurorescent moiety (FLU) anthracene-9-carboxylic acid and verified by ~1H-NMR. PEG-PLGA-FLU NPs were prepared by co-nanoprecipitation of PEG-PLGA and PLGA-FLU and subsequently characterized for their size, polydispersity and charge (DLS/ELS) and surface chemical composition (NMR of NP souspension). Endothelial cells were isolated from adult mice brains, then selected by puromycine (2 days) and cultivated in a home-designed conditioning medium (5 days.) Confluent cells were plated in 24-well Transwell plates. 24-h later, cells were treated with an equivalent amoount of the various PEG-PLGA-FLU NPs; FLU-PLGA NPs served as controls. Transcytosis was quantified by fluorescent detection in both compartments. Endocytosis was monitored by confocal microscopy. A diblock polymer library was created and characterized. Expected molecular weights and PEG content were found, with an overall grafting efficiency ≥ 90%. PEG length affects NP size and surface properties. Thus, nanoprecipitation parameters were optimized to obtain a near-constant NP diameter regardless of the PEG chain lengths to eliminate the confounding effect of NP size on BBB passage. An in vitro BBB permeability assay was designed from primary endothelial cells. Expression of P-gp, GLUT-1, OATP and CAT transporters was used to validate the biorelevancy of transport mechanisms. TEER and Lucifer yellow allowed to assess the model tightness. The effect of PEG length on endothelial cell translocation has been being investigated.
机译:血脑屏障(BBB)充当中枢神经系统(CNS)与体循环之间的物理和代谢屏障。这种复杂的细胞组装可为大多数治疗性分子提供保护性,准不可渗透的屏障。纳米技术已经以各种成功率被使用来克服这个问题。尤其是,已经广泛研究了由FDA批准的,接枝有聚乙二醇(PEG)的聚(0,L-丙交酯-乙交酯)(PLGA)的纳米颗粒(NP)。这种替代方法使它们减少了毒性,延长了循环时间,并增加了血脑屏障的渗透性。然而,到目前为止,还没有系统的研究来探讨PEG链长对BBB内吞和NP胞吞作用的作用。因此,本研究旨在根据PEG链长比较PEG-PLGA纳米颗粒跨主要内皮细胞模型的转运速率。如先前报道的,通过PLGA链(24kDa)和不同长度(1,2,5和10kDa)的mPEG链之间的DCC偶联反应合成了PEG化的二嵌段聚合物。聚合物通过GPC,〜1H-NMR和FTIR表征。平行地,PLGA链被荧光部分(FLU)蒽9-羧酸共价标记,并通过〜1H-NMR验证。 PEG-PLGA-FLU NP是通过PEG-PLGA和PLGA-FLU的共纳米沉淀制备的,随后对其尺寸,多分散性和电荷(DLS / ELS)和表面化学组成(NP悬浮液的NMR)进行了表征。从成年小鼠的大脑中分离出内皮细胞,然后用嘌呤霉素选择(2天),并在家庭设计的条件培养基中培养(5天)。将融合细胞铺在24孔Transwell平板中。 24小时后,将细胞用等效的各种PEG-PLGA-FLU NP溶液处理; FLU-PLGA NP用作对照。通过在两个隔室中的荧光检测对转胞吞作用进行定量。通过共聚焦显微镜监测胞吞作用。创建并表征了二嵌段聚合物库。发现了预期的分子量和PEG含量,总接枝效率≥90%。 PEG的长度会影响NP的大小和表面性质。因此,优化了纳米沉淀参数以获得近乎恒定的NP直径,而不管PEG链长如何,从而消除了NP大小对BBB通道的混杂影响。从原代内皮细胞设计了体外BBB通透性测定。 P-gp,GLUT-1,OATP和CAT转运蛋白的表达用于验证转运机制的生物相关性。 TEER和Lucifer Yellow可以评估模型的密封性。已经研究了PEG长度对内皮细胞易位的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号